Your browser doesn't support javascript.
loading
Erufosine increases RhoB expression in oral squamous carcinoma cells independent of its tumor suppressive mode of action - a short report.
Ansari, Shariq S; Akgün, Nurullah; Berger, Martin R.
Affiliation
  • Ansari SS; Toxicology and Chemotherapy Unit, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 581, 69120, Heidelberg, Germany.
  • Akgün N; Toxicology and Chemotherapy Unit, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 581, 69120, Heidelberg, Germany.
  • Berger MR; Toxicology and Chemotherapy Unit, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. m.berger@dkfz.de.
Cell Oncol (Dordr) ; 40(1): 89-96, 2017 Feb.
Article in En | MEDLINE | ID: mdl-27812856

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organophosphates / Mouth Neoplasms / Carcinoma, Squamous Cell / RhoB GTP-Binding Protein / Quaternary Ammonium Compounds / Antineoplastic Agents Limits: Humans Language: En Journal: Cell Oncol (Dordr) Year: 2017 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organophosphates / Mouth Neoplasms / Carcinoma, Squamous Cell / RhoB GTP-Binding Protein / Quaternary Ammonium Compounds / Antineoplastic Agents Limits: Humans Language: En Journal: Cell Oncol (Dordr) Year: 2017 Type: Article Affiliation country: Germany